Insights

Everyone needs a knowledge refresher now and then. Our new course builds a solid foundation for better returns.

Alex Gluyas catches up with the CEO and Managing Director of Dimerix Limited, Nina Webster, to discuss its DMX-200 drug candidate which can be used to treat acute respiratory distress syndrome in COVID-19 patients and has recently been included in the REMAP-CAP study, a pandemic special study endorsed by the WHO.

Theo Marinis runs through three simple tests to use when figuring out if a financial planner is willing to go the distance for you.

It's a sell-off special this week with directors in charge of some well-performing ASX200 companies deciding to lock in their gains.

Steve Sammartino explains why investors need to be looking at new forms of abundance and scarcity, as these themes combined historically result in 'corporate heroes'.

Alex Gluyas speaks with the Managing Director of Brickworks, Lindsay Partridge, about the increasing demand for industrial property and warehouse facilities, how COVID has impacted its Building Products arm in the US and how its large position in Washington H Soul Pattinson allows it to consistently pay out a dividend.

In my work for Eureka Report, I interview a lot of fund managers. They're almost always good people, and almost always men, and usually very nerdy men at that.

In the first of her three-part series, Lisa Papachristoforos looks at what to provide your accountant from an asset and liability perspective when preparing your annual SMSF compliance work.

Over 11 million Australians hold investments of some sort outside their super. But this could be higher. There is still a significant minority of people who do not invest.

Scott Francis explains why the age pension asset test taper rate that was in place prior to January 2017, is fairer than the current system.

As accountants and finance staff everywhere quietly celebrate the end of another financial year, we look forward to FY21, which is sure to be heavily dominated by the COVID-19 crisis.

A landmark partnership with Mastercard a fortnight ago sent Splitit's share price surging, Alex Gluyas caught up with the company's CEO, Brad Paterson, to discuss the partnership and what sets it apart from other buy now pay later companies.

Robert Gottliebsen explains why a recent statement by the US Government's Centre for Disease Control and Prevention provides an ominous warning for the US economy, and runs through what lessons bondholders can learn from Virgin's collapse.

As if we didn't have enough to deal with right now, Australia's money watchdog ASIC is reporting a rise in investment scams during the COVID-19 pandemic.

We take a look at some strategies that have weathered the storm

With international borders closed for the foreseeable future, Alex Gluyas looks at the travel booking stocks that are best placed to capitalise on the pent-up urge to travel as some states look to ease restrictions.